Charles Duncan

Stock Analyst at Cantor Fitzgerald

Total Price Targets

4

Stocks Covered

4

Sectors

Healthcare

Most Recent

Jul 21, 2025

Notable Calls (Last 12 Months)

Most Bullish

SLDB+136.7%
Solid Biosciences Inc.
$16.00 targetJul 21, 2025

Most Bearish

SLDB+136.7%
Solid Biosciences Inc.
$16.00 targetJul 21, 2025

Stocks Covered by Charles Duncan

Symbol	Company	Latest Target	Current Price	Upside	# Targets	Last Updated
SLDB	Solid Biosciences Inc.	$16.00	$7.14	+123.9%	1	Jul 21, 2025
VNDA	Vanda Pharmaceuticals Inc.	$11.00	$7.08	+55.5%	1	Jul 11, 2024
NVAX	Novavax, Inc.	$174.00	$8.04	+2065.5%	1	Feb 14, 2022
NBIX	Neurocrine Biosciences, Inc.	$123.00	$131.64	-6.6%	1	Nov 2, 2021

Recent Activity

Jul 21, 2025— Set$16.00price target onSLDB(Solid Biosciences Inc.)
Jul 11, 2024— Set$11.00price target onVNDA(Vanda Pharmaceuticals Inc.)
Feb 14, 2022— Set$174.00price target onNVAX(Novavax, Inc.)
Nov 2, 2021— Set$123.00price target onNBIX(Neurocrine Biosciences, Inc.)

Frequently Asked Questions

Who is Charles Duncan?

Charles Duncan is a stock analyst at Cantor Fitzgerald covering 4 stocks primarily in Healthcare. They have issued 4 price targets since Nov 2, 2021.

What stocks does Charles Duncan cover?

Charles Duncan currently covers 4 stocks, including SLDB, VNDA, NVAX, NBIX.

What is Charles Duncan's latest price target?

Charles Duncan's most recent price target was $16.00 on SLDB (Solid Biosciences Inc.), set on Jul 21, 2025.

What is Charles Duncan's highest price target?

Charles Duncan's highest issued price target is $174.00 on NVAX, set on Feb 14, 2022.

More Analysts at Cantor Fitzgerald

Deepak Mathivanan

Cantor Fitzgerald

Brett Knoblauch

Cantor Fitzgerald

Andres Sheppard

Cantor Fitzgerald

Jonathan Ruykhaver

Cantor Fitzgerald

Coverage based on publicly published price targets. Not investment advice.